Tata Steel Ltd Partly Paid Up, HFCL Ltd, KEI Industries Ltd and Dr Reddys Laboratories Ltd are among the other losers in the BSE s A group today, 29 January 2021.
Tata Steel Ltd Partly Paid Up, HFCL Ltd, KEI Industries Ltd and Dr Reddys Laboratories Ltd are among the other losers in the BSE s A group today, 29 January 2021.
Havells India Ltd crashed 10.37% to Rs 1060.25 at 14:48 IST.The stock was the biggest loser in the BSE s A group.On the BSE, 10.03 lakh shares were traded on the counter so far as against the average daily volumes of 1.33 lakh shares in the past one month.
The vaccine development process by Bharat Biotech, Biological E Ltd and Aurobindo Pharma are in various stages. Hyderabad set to emerge as global hub for COVID-19 vaccine in 2021. | Photo Credit: AP
As the world is set to brace for a new year amid the COVID-19 pandemic, the city is poised to emerge as a saviour from the killer virus, with as many as five vaccine manufacturing firms based here racing to bring out an antidote.
The vaccine development process by Bharat Biotech, Biological E Ltd and Aurobindo Pharma are currently in various stages, while Dr Reddy s and Hetero have tie ups for manufacturing the vaccine.
Technavio Research: Tobacco Alternative Gums Market 2020-2024 - Featuring Alchem International Pvt. Ltd., Cambrex Corp., Cipla Inc., Among Others to Contribute for the Market Growth
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201223005579/en/
Technavio has announced its latest market research report titled Global Tobacco Alternative Gums Market 2020-2024 (Graphic: Business Wire)
Worried about the impact of COVID-19 on your Business? Here is an Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour.
Get FREE Sample Report in Minutes!
The report on the tobacco alternative gums market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
Global Biosimilar Monoclonal Antibodies Market Report 2020-2030: COVID-19 Impact, Growth and Changes
ResearchAndMarkets.com s offering. Biosimilar Monoclonal Antibodies Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global biosimilar monoclonal antibodies market. Major players in the biosimilar monoclonal antibodies market are Pfizer, Novartis, Allergan, Coherus BioSciences, Biocon, Amgen, Boehringer Ingelheim, Celltrion, BioXpress Therapeutics, and Intas Pharmaceuticals Limited.
The global biosimilar monoclonal antibodies market is expected to decline from $3.21 billion in 2019 to $3.04 billion in 2020 at a compound annual growth rate (CAGR) of -5.18%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activitie